Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
Total study duration is 3 to 10 weeks, including a screening period of 27 days, treatment period of up to 15 days and a follow-up and end of study of up to 4 weeks.
Age
30–65
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Healthy male subjects 30 to 65 years of age. Body Mass Index 18 up to 32 kg/m2, inclusive. Signed informed consent. Subjects must agree to the use of an adequate method of contraception for up to 3 months after discharge from the clinical unit
You may not be if
Radiation exposure exceeding 5 millisievert (mSv) in the last 12 months or 10 mSv in the last five years (including diagnostic X-rays and other medical exposures).
Occupationally exposure to radiation (as defined in the Ionizing Radiations Regulations 2017).
Irregular bowel habits (more than 3 bowel movements/day or less than 1 every 2 days) .
Social habits: smoking, alcohol abuse, drug abuse etc.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
